The role of immunomodulatory metabolites in shaping the inflammatory response of macrophages

키워드

참고문헌 (92)

1. Fullerton JN, "Resolution of inflammation : a new therapeutic frontier", Nat Rev Drug Discov, 15, pp.551~567 (2016)
2. Netea MG, "A guiding map for inflammation", Nat Immunol, 18, pp.826~831 (2017)
3. Turner MD, "Cytokines and chemokines : at the crossroads of cell signalling and inflammatory disease", Biochim Biophys Acta, 1843, pp.2563~2582 (2014)
4. Fujiwara N, "Macrophages in inflammation", Curr Drug Targets Inflamm Allergy, 4, pp.281~286 (2005)
5. Watanabe S, "The role of macrophages in the resolution of inflammation", J Clin Invest, 129, pp.2619~2628 (2019)
6. Arango Duque G, "Macrophage cytokines : involvement in immunity and infectious diseases", Front Immunol, 5, pp.491~ (2014)
7. Buck MD, "Metabolic instruction of immunity", Cell, 169, pp.570~586 (2017)
8. O’Neill LA, "A guide to immunometabolism for immunologists", Nat Rev Immunol, 16, pp.553~565 (2016)
9. Makowski L, "Immunometabolism : from basic mechanisms to translation", Immunol Rev, 295, pp.5~14 (2020)
10. Warburg O, "On the origin of cancer cells", Science, 123, pp.309~314 (1956)
11. Liberti MV, "The warburg effect : how does it benefit cancer cells?", Trends Biochem Sci, 41, pp.211~218 (2016)
12. Kelly B, "Metabolic reprogramming in macrophages and dendritic cells in innate immunity", Cell Res, 25, pp.771~784 (2015)
13. Jackson SH, "The p47phox mouse knock-out model of chronic granulomatous disease", J Exp Med, 182, pp.751~758 (1995)
14. Hagg D, "Oxidized LDL induces a coordinated up-regulation of the glutathione and thioredoxin systems in human macrophages", Atherosclerosis, 185, pp.282~289 (2006)
15. Hibbs JB Jr, "Nitric oxide : a cytotoxic activated macrophage effector molecule", Biochem Biophys Res Commun, 157, pp.87~94 (1988)
16. Rath M, "Metabolism via arginase or nitric oxide synthase : two competing arginine pathways in macrophages", Front Immunol, 5, pp.532~ (2014)
17. Anders CB, "Metabolic immunomodulation of macrophage functional plasticity in nonhealing wounds", Curr Opin Infect Dis, 32, pp.204~209 (2019)
18. Nakrani MN, "statpearls" (2022), treasure island (FL)
19. Freemerman AJ, "Metabolic reprogramming of macrophages : glucose transporter 1(GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype", J Biol Chem, 289, pp.7884~7896 (2014)
20. Blagih J, "Polarizing macrophages through reprogramming of glucose metabolism", Cell Metab, 15, pp.793~795 (2012)
21. Yamashita H, "A glucose-responsive transcription factor that regulates carbohydrate metabolism in the liver", Proc Natl Acad Sci U S A, 98, pp.9116~9121 (2001)
22. Kawaguchi T, "Glucose and cAMP regulate the L-type pyruvate kinase gene by phosphorylation", dephosphorylation of the carbohydrate response element binding protein, 2001, pp.98, 13710~13715
23. Abdul-Wahed A, "Sweet sixteenth for ChREBP : established roles and future goals", Cell Metab, 26, pp.324~341 (2017)
24. Iizuka K, "ChREBP-mediated regulation of lipid metabolism : involvement of the gut microbiota, liver, and adipose tissue", Front Endocrinol(Lausanne), 11, pp.587189~ (2020)
25. Ortega-Prieto P, "Carbohydrate sensing through the transcription factor ChREBP", Front Genet, 10, pp.472~ (2019)
26. Sarrazy V, "Maintenance of macrophage redox status by ChREBP limits inflammation and apoptosis and protects against advanced atherosclerotic lesion formation", Cell Rep, 13, pp.132~144 (2015)
27. Jha AK, "Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization", Immunity, 42, pp.419~430 (2015)
28. Lane EA, "HCF-1regulates de novo lipogenesis through a nutrient-sensitive complex with ChREBP", Mol Cell, 75, pp.357~371 (2019)
29. Xiao D, "The glutamine-alpha-ketoglutarate(AKG)metabolism and its nutritional implications", Amino Acids, 48, pp.2067~2080 (2016)
30. Liu S, "The regulatory role of alpha-ketoglutarate metabolism in macrophages", Mediators Inflamm, 2021, pp.5577577~ (2021)
31. Schofield CJ, "Structural and mechanistic studies on 2-oxoglutarate-dependent oxygenases and related enzymes", Curr Opin Struct Biol, 9, pp.722~731 (1999)
32. Kaelin WG Jr, "Molecular basis of the VHL hereditary cancer syndrome", Nat Rev Cancer, 2, pp.673~682 (2002)
33. Cummins EP, "Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity", Proc Natl Acad Sci U S A, 103, pp.18154~18159 (2006)
34. Cheng MX, "Alpha-ketoglutarate attenuates ischemia-reperfusion injury of liver graft in rats", Biomed Pharmacother, 111, pp.1141~1146 (2019)
35. Wilson MG, "Prenatal diagnosis of mosaicism for del(18)(q12. 2q21. 1)and a normal cell line", J Med Genet, 25, pp.635~636 (1988)
36. Chin RM, "The metabolite alpha-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR", Nature, 510, pp.397~401 (2014)
37. Tran KA, "The role of alpha-ketoglutarate-dependent proteins in pluripotency acquisition and maintenance", J Biol Chem, 294, pp.5408~5419 (2019)
38. Liu PS, "Alpha-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming", Nat Immunol, 18, pp.985~994 (2017)
39. Tannahill GM, "Succinate is an inflammatory signal that induces IL-1beta through HIF-1alpha", Nature, 496, pp.238~242 (2013)
40. Harber KJ, "Succinate is an inflammation-induced immunoregulatory metabolite in macrophages", Metabolites, 10, pp.372~ (2020)
41. Selak MA, "Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase", Cancer Cell, 7, pp.77~85 (2005)
42. Palsson-McDermott EM, "Pyruvate kinase M2 regulates Hif-1alpha activity and IL-1beta induction and is a critical determinant of the warburg effect in LPS-activated macrophages", Cell Metab, 21, pp.65~80 (2015)
43. Mills EL, "Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages", Cell, 167, pp.457~470 (2016)
44. Elia I, "Metabolites and the tumour microenvironment : from cellular mechanisms to systemic metabolism", Nat Metab, 3, pp.21~32 (2021)
45. Fremder M, "A transepithelial pathway delivers succinate to macrophages, thus perpetuating their pro-inflammatory metabolic state", Cell Rep, 36, pp.109521~ (2021)
46. Keiran N, "SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity", Nat Immunol, 20, pp.581~592 (2019)
47. Trauelsen M, "Extracellular succinate hyperpolarizes M2 macrophages through SUCNR1", GPR91-mediated Gq signaling, 2021, pp.35, 109246~
48. Yang Y, "Succinylation links metabolism to protein functions", Neurochem Res, 44, pp.2346~2359 (2019)
49. Alleyn M, "The dawn of succinylation : a posttranslational modification", Am J Physiol Cell Physiol, 314, pp.C228~ (2018)
50. Zhang Z, "Identification of lysine succinylation as a new post-translational modification", Nat Chem Biol, 7, pp.58~63 (2011)
51. Rardin MJ, "SIRT5 regulates the mitochondrial lysine succinylome and metabolic networks", Cell Metab, 18, pp.920~933 (2013)
52. Arts RJ, "Glutaminolysis and fumarate accumulation integrate immunometabolic and epigenetic programs in trained immunity", Cell Metab, 24, pp.807~819 (2016)
53. Ivashkiv LB, "Epigenetic regulation of macrophage polarization and function", Trends Immunol, 34, pp.216~223 (2013)
54. Tong WH, "The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels", Cancer Cell, 20, pp.315~327 (2011)
55. Cummins EP, "The role of HIF in immunity and inflammation", Mol Aspects Med, 47-48, pp.24~34 (2016)
56. Han R, "Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2", hemoxygenase-1 pathway by altering the balance of M1, J Neuroinflammation, pp.2016, 13[DOI]
57. Majkutewicz I, "Dimethyl fumarate : a review of preclinical efficacy in models of neurodegenerative diseases", Eur J Pharmacol, 926, pp.175025~ (2022)
58. Brennan MS, "Dimethyl fumarate and monoethyl fumarate exhibit differential effects on KEAP1, NRF2 activation, and glutathione depletion in vitro", PLoS One, 10, pp.e0120254~ (2015)
59. Blatnik M, "Succination of proteins by fumarate : mechanism of inactivation of glyceraldehyde-3-phosphate dehydrogenase in diabetes", Ann N Y Acad Sci, 1126, pp.272~275 (2008)
60. Jove M, "Succination of protein thiols in human brain aging", Front Aging Neurosci, 12, pp.52~ (2020)
61. Nagai R, "Succination of protein thiols during adipocyte maturation : a biomarker of mitochondrial stress", J Biol Chem, 282, pp.34219~34228 (2007)
62. Ruecker N, "Fumarase deficiency causes protein and metabolite succination and intoxicates mycobacterium tuberculosis", Cell Chem Biol, 24, pp.306~315 (2017)
63. O’Neill LAJ, "Itaconate : the poster child of metabolic reprogramming in macrophage function", Nat Rev Immunol, 19, pp.273~281 (2019)
64. Michelucci A, "Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production", Proc Natl Acad Sci U S A, 110, pp.7820~7825 (2013)
65. Peace CG, "The role of itaconate in host defense and inflammation", J Clin Invest, 132, pp.e148548~ (2022)
66. Chen M, "Itaconate is an effector of a Rab GTPase cell-autonomous host defense pathway against Salmonella", Science, 369, pp.450~455 (2020)
67. Ruetz M, "Itaconyl-CoA forms a stable biradical in methylmalonylCoA mutase and derails its activity and repair", Science, 366, pp.589~593 (2019)
68. Lampropoulou V, "Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation", Cell Metab, 24, pp.158~166 (2016)
69. Zhu X, "Itaconic acid exerts anti-inflammatory and antibacterial effects via promoting pentose phosphate pathway to produce ROS", Sci Rep, 11, pp.18173~ (2021)
70. Mills EL, "Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1", Nature, 556, pp.113~117 (2018)
71. Liao ST, "4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects", Nat Commun, 10, pp.5091~ (2019)
72. Hooftman A, "The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation", Cell Metab, 32, pp.468~478 (2020)
73. Daniels BP, "The nucleotide sensor ZBP1 and kinase RIPK3 induce the enzyme IRG1 to promote an antiviral metabolic state in neurons", Immunity, 50, pp.64~76 (2019)
74. He R, "Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsisinduced acute lung injury", Cell Death Discov, 8, pp.43~ (2022)
75. Ogger PP, "Itaconate controls the severity of pulmonary fibrosis", Sci Immunol, 5, pp.eabc1884~ (2020)
76. Sohail A, "Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection", PLoS Pathog, 18, pp.e1010219~ (2022)
77. Jaiswal AK, "Irg1", itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation, 2022, pp.15, 301~313
78. Zhang S, "Dimethyl itaconate alleviates the inflammatory responses of macrophages in sepsis", Inflammation, 44, pp.549~557 (2021)
79. Hooftman A, "The immunomodulatory potential of the metabolite itaconate", Trends Immunol, 40, pp.687~698 (2019)
80. ElAzzouny M, "Dimethyl itaconate is not metabolized into itaconate intracellularly", J Biol Chem, 292, pp.4766~4769 (2017)
81. Swain A, "Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages", Nat Metab, 2, pp.594~602 (2020)
82. Dominguez-Andres J, "The itaconate pathway is a central regulatory node linking innate immune tolerance and trained immunity", Cell Metab, 29, pp.211~220 (2019)
83. Runtsch MC, "Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages", Cell Metab, 34, pp.487~501 (2022)
84. Zhang Z, "Itaconate is a lysosomal inducer that promotes antibacterial innate immunity", Mol Cell, 82, pp.2844~2857 (2022)
85. Schuster EM, "TFEB induces mitochondrial itaconate synthesis to suppress bacterial growth in macrophages", Nat Metab, 4, pp.856~866 (2022)
86. Yoo HJ, "MsrB1-regulated GAPDH oxidation plays programmatic roles in shaping metabolic and inflammatory signatures during macrophage activation", Cell Rep, 41, pp.111598~ (2022)
87. Wong Fok Lung T, "Klebsiella pneumoniae induces host metabolic stress that promotes tolerance to pulmonary infection", Cell Metab, 34, pp.761~774 (2022)
88. Cameron AM, "Inflammatory macrophage dependence on NAD(+)salvage is a consequence of reactive oxygen species-mediated DNA damage", Nat Immunol, 20, pp.420~432 (2019)
89. Wellen KE, "ATP-citrate lyase links cellular metabolism to histone acetylation", Science, 324, pp.1076~1080 (2009)
90. Infantino V, "ATP-citrate lyase is essential for macrophage inflammatory response", Biochem Biophys Res Commun, 440, pp.105~111 (2013)
91. Hu L, "Epigenetic regulation of interleukin 6 by histone acetylation in macrophages and its role in paraquat-induced pulmonary fibrosis", Front Immunol, 7, pp.696~ (2016)
92. Palmieri EM, "Pharmacologic or genetic targeting of glutamine synthetase skews macrophages toward an M1-like phenotype and inhibits tumor metastasis", Cell Rep, 20, pp.1654~1666 (2017)

관련 논문AI추천